Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway.
about
Alterations of the intracellular peptidome in response to the proteasome inhibitor bortezomibA quantitative microfluidic angiogenesis screen for studying anti-angiogenic therapeutic drugs.pH/NIR Light-Controlled Multidrug Release via a Mussel-Inspired Nanocomposite Hydrogel for Chemo-Photothermal Cancer TherapyChemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expressionA new isoquinolinium derivative, Cadein1, preferentially induces apoptosis in p53-defective cancer cells with functional mismatch repair via a p38-dependent pathway.Leucovorin Enhances the Anti-cancer Effect of Bortezomib in Colorectal Cancer Cells.Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluationProfiling human protein degradome delineates cellular responses to proteasomal inhibition and reveals a feedback mechanism in regulating proteasome homeostasis.Down-regulation of 11β-hydroxysteroid dehydrogenase type 2 by bortezomib sensitizes Jurkat leukemia T cells against glucocorticoid-induced apoptosis.Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survivalBortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancerCombined bortezomib-based chemotherapy and p53 gene therapy using hollow mesoporous silica nanospheres for p53 mutant non-small cell lung cancer treatment.Emerging drugs for esophageal cancer.Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China.Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphomaTargeted treatments for metastatic esophageal squamous cell cancerRole of cysteine 288 in nucleophosmin cytoplasmic mutations: sensitization to toxicity induced by arsenic trioxide and bortezomib.Esophageal 3D Culture Systems as Modeling Tools in Esophageal Epithelial Pathobiology and Personalized Medicine.Short duration cancer treatment: inspired by a fast bio-resorbable smart nano-fiber device containing NIR lethal polydopamine nanospheres for effective chemo-photothermal cancer therapy
P2860
Q21090814-AEC75C4F-910D-4CDD-B31B-942F7A3C5A4BQ27335560-B769471B-8617-46A8-9373-4AC94D0F7711Q27347647-EDF54C9E-BF7C-4236-9276-BBF01AAEF5FBQ28535295-154C57E3-36E3-4EB2-9EC9-8BFE5D2AEE02Q33516915-13228983-EB6A-4303-8DF3-8C82A44D10E7Q33677971-05FAB5C2-EF1E-4704-A362-369214C1B4D3Q33886981-45D3B533-BBF9-40D4-B7EF-7D1366F61A92Q34289909-A741C0E4-1011-49BE-85D1-3079C3C79013Q34796376-E8DE4C41-FC04-45C3-B626-6BDC837EFA79Q35667126-72BCC058-8186-46C2-94ED-2BFD2AA3CAD9Q35836881-37B97E97-75EA-4FC5-A726-1F4396BC8D35Q36012586-CFAF099E-27B2-4533-A6A0-79F9F0B3DFB6Q36185176-4D590A17-4C7D-4C07-B6C3-285E9A3650D5Q37488281-8C5E9EB4-8B50-4E9C-B596-7CB6D906837CQ38052131-1599923B-F1EF-447E-8319-05D8832709B5Q38491448-7F4585CD-BDE9-44FC-BB9B-4E4F34341818Q39318989-A63EC3A0-DB05-4115-A0B4-4FA129D89501Q39671092-D231CCD8-A6C1-43CE-AEDC-022DE76F9A16Q42070740-237652ED-6BD4-4E1B-A278-EC5BEBDB2DA6Q42154615-2EADAF19-745B-434E-B48A-8FF519823A1CQ42710172-C091D8A0-7D98-4790-B2D6-D31349BC8D1FQ52715285-DA37F22A-7B39-4258-8E72-3396CCCB56F0Q58570176-76BD1C3B-F5EE-4DC8-AEFA-F40254E91524
P2860
Bortezomib induces apoptosis in esophageal squamous cell carcinoma cells through activation of the p38 mitogen-activated protein kinase pathway.
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Bortezomib induces apoptosis i ...... ivated protein kinase pathway.
@ast
Bortezomib induces apoptosis i ...... ivated protein kinase pathway.
@en
type
label
Bortezomib induces apoptosis i ...... ivated protein kinase pathway.
@ast
Bortezomib induces apoptosis i ...... ivated protein kinase pathway.
@en
prefLabel
Bortezomib induces apoptosis i ...... ivated protein kinase pathway.
@ast
Bortezomib induces apoptosis i ...... ivated protein kinase pathway.
@en
P2093
P2860
P1476
Bortezomib induces apoptosis i ...... ivated protein kinase pathway.
@en
P2093
Andres Klein-Szanto
Andrew Snyder
Anil K Rustgi
J Alan Diehl
Kazuhiro Noma
Mercedes Lioni
P2860
P304
P356
10.1158/1535-7163.MCT-08-0391
P577
2008-09-01T00:00:00Z